Stay updated with breaking news from Small Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Caner Immunotherapy Pilot Program/Patents 4 Patients program has been extend through January 31, the Fast-Track Appeals Pilot Program has been extended through July 2, 2024, and the After Final Consideration Pilot AFCP Program 2.0 has been extended to September 30, 2023
The US Patent & Trademark Office USPTO announced an extension of the modified COVID-19 Prioritized Examination Pilot Program. Compliant requests filed on or before March 31, 2022, will be accepted.
USPTO Changes Small Entity Rules To Promote CRADAs Tuesday, February 2, 2021 While I stand by my view that the doctrine of obviousness-type double patenting is one of the most complicated aspects of U.S. patent law, regulations governing the ability to claim “Small Entity” status and pay reduced USPTO fees come a close second. In a final rule effective January 20, 2021, the USPTO revised its Small Entity rules to remove disincentives of collaborating with the Federal government by, for example, making the impact of Federal agency rights to inventions made under “Cooperative ...